2Schnurr M, Chen Q, Shin A, et al. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of an?tigen delivery[J]. Blood, 2005,105(6): 2465 -2472.
3Honda K, Yanai H, Negishi H, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses[J]. Nature, 2005, 434 (7034) : 772 -777.
4Folkl A, Bienzle D. Structure and function of programmed death (PD) molecules[J]. Vet Immunol Immunopathol, 2010,134(1/2): 33 -38.
5Chen Y, Liu P, Gao F, et al. A dimeric structure of PD-Ll: function- al units or evolutionary relics[J]. Protein Cell, 20 I 0, I (2): 153 - 160.
6Inman B A , Sebo TJ, Frigola X, et at. PD-L! ( B7 -HI) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression[J]. Cancer, 2007, 109 (8): 1499 -1505.
7Figdor C G, de-Vries IJ, Lesterhuis WJ, et at. Dendritic cell immu?notherapy: mapping the way[J]. Nat Med, 2008, 10 (5) : 475 -480.
8Prechtel AT, Steinkasserer A. CD83: an update on functions and prospects of the maturation marker of dendritic cells[J]. Arch Derma?tol Hes, 2007,299(2) : 59 -69.
9Choi Y K, Kim YJ, Park H S, et at. Suppression of glomerulosclero?sis by adenovirus-mediated IL- 10 expression in the kidney[J]. Gene Ther, 2003, 10 ( 7) : 559 - 568.
10Kim H K, Guan H, Zu G, et at. High-level expression of B7-HI molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals[J].J Leukoc Bioi, 2006,79(4): 686 -669.
